196 related articles for article (PubMed ID: 33627783)
1. E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
Ahmed SF; Buetow L; Gabrielsen M; Lilla S; Sibbet GJ; Sumpton D; Zanivan S; Hedley A; Clark W; Huang DT
Oncogene; 2021 Mar; 40(12):2149-2164. PubMed ID: 33627783
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.
Sato S; Zhao Y; Imai M; Simister PC; Feller SM; Trackman PC; Kirsch KH; Sonenshein GE
PLoS One; 2013; 8(10):e77288. PubMed ID: 24167568
[TBL] [Abstract][Full Text] [Related]
3. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
[TBL] [Abstract][Full Text] [Related]
4. CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells.
Niiro H; Jabbarzadeh-Tabrizi S; Kikushige Y; Shima T; Noda K; Ota S; Tsuzuki H; Inoue Y; Arinobu Y; Iwasaki H; Shimoda S; Baba E; Tsukamoto H; Horiuchi T; Taniyama T; Akashi K
Blood; 2012 Mar; 119(10):2263-73. PubMed ID: 22262777
[TBL] [Abstract][Full Text] [Related]
5. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.
Haglund K; Schmidt MHH; Wong ES; Guy GR; Dikic I
EMBO Rep; 2005 Jul; 6(7):635-41. PubMed ID: 15962011
[TBL] [Abstract][Full Text] [Related]
6. The basic amino acids in the coiled-coil domain of CIN85 regulate its interaction with c-Cbl and phosphatidic acid during epidermal growth factor receptor (EGFR) endocytosis.
Zheng X; Zhang J; Liao K
BMC Biochem; 2014 Jul; 15():13. PubMed ID: 25005938
[TBL] [Abstract][Full Text] [Related]
7. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
[TBL] [Abstract][Full Text] [Related]
8. Adaptor protein complex of FRS2β and CIN85/CD2AP provides a novel mechanism for ErbB2/HER2 protein downregulation.
Minegishi Y; Shibagaki Y; Mizutani A; Fujita K; Tezuka T; Kinoshita M; Kuroda M; Hattori S; Gotoh N
Cancer Sci; 2013 Mar; 104(3):345-52. PubMed ID: 23279575
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors.
Kowanetz K; Szymkiewicz I; Haglund K; Kowanetz M; Husnjak K; Taylor JD; Soubeyran P; Engstrom U; Ladbury JE; Dikic I
J Biol Chem; 2003 Oct; 278(41):39735-46. PubMed ID: 12874286
[TBL] [Abstract][Full Text] [Related]
10. Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination.
Bezsonova I; Bruce MC; Wiesner S; Lin H; Rotin D; Forman-Kay JD
Biochemistry; 2008 Aug; 47(34):8937-49. PubMed ID: 18680311
[TBL] [Abstract][Full Text] [Related]
11. Cbl E3 Ligase Mediates the Removal of Nectin-1 from the Surface of Herpes Simplex Virus 1-Infected Cells.
Deschamps T; Dogrammatzis C; Mullick R; Kalamvoki M
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381567
[TBL] [Abstract][Full Text] [Related]
12. SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex.
Feng L; Wang JT; Jin H; Qian K; Geng JG
Cell Biochem Funct; 2011 Oct; 29(7):589-96. PubMed ID: 21830225
[TBL] [Abstract][Full Text] [Related]
13. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
14. CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases.
Szymkiewicz I; Kowanetz K; Soubeyran P; Dinarina A; Lipkowitz S; Dikic I
J Biol Chem; 2002 Oct; 277(42):39666-72. PubMed ID: 12177062
[TBL] [Abstract][Full Text] [Related]
15. Casitas B-lineage lymphoma linker helix mutations found in myeloproliferative neoplasms affect conformation.
Buetow L; Tria G; Ahmed SF; Hock A; Dou H; Sibbet GJ; Svergun DI; Huang DT
BMC Biol; 2016 Sep; 14(1):76. PubMed ID: 27609087
[TBL] [Abstract][Full Text] [Related]
16. The E3 ubiquitin ligase Cbl-b inhibits tumor growth in multidrug-resistant gastric and breast cancer cells.
CHe X; Zhang Y; Qu X; Guo T; Ma Y; Li C; Fan Y; Hou K; Cai Y; Yu R; Zhou H; He X; Wu H; Liu Y; Xu L
Neoplasma; 2017; 64(6):887-892. PubMed ID: 28895413
[TBL] [Abstract][Full Text] [Related]
17. Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth.
Wisniewski DJ; Liyasova MS; Korrapati S; Zhang X; Ratnayake S; Chen Q; Gilbert SF; Catalano A; Voeller D; Meerzaman D; Guha U; Porat-Shliom N; Annunziata CM; Lipkowitz S
J Biol Chem; 2023 Jan; 299(1):102766. PubMed ID: 36470425
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl.
Take H; Watanabe S; Takeda K; Yu ZX; Iwata N; Kajigaya S
Biochem Biophys Res Commun; 2000 Feb; 268(2):321-8. PubMed ID: 10679202
[TBL] [Abstract][Full Text] [Related]
19. Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.
Schmidt MHH; Hoeller D; Yu J; Furnari FB; Cavenee WK; Dikic I; Bögler O
Mol Cell Biol; 2004 Oct; 24(20):8981-93. PubMed ID: 15456872
[TBL] [Abstract][Full Text] [Related]
20. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.
Nam JM; Onodera Y; Mazaki Y; Miyoshi H; Hashimoto S; Sabe H
EMBO J; 2007 Feb; 26(3):647-56. PubMed ID: 17255943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]